
To maintain affordable and high-quality healthcare services a pivot is needed from traditional curative health care to preventive health care. Primary care health professionals are eager to use new methods to accommodate this shift but lack the technology, scale, and data science to move forward. Current standard blood tests are invasive, infrequent, and often over- or underestimate the risk for metabolic diseases. To achieve effective preventive health care, personalized tests are essential.
Maven Health generates an accurate picture of personal metabolic health through our proprietary data platform which combines machine learning algorithms, data infrastructure and metabolomics. The goal is to empower primary healthcare providers to identify people at risk of metabolic diseases but who would otherwise be missed by the traditional healthcare system. Maven Health closely collaborates with primary care providers to finetune the specific targets and outcomes of their testing, making their outputs directly applicable to the current healthcare system.
The health analyses are generated from the metabolite profiles of saliva, which is collected non-invasively. Metabolites are measured by Nuclear Magnetic Resonance, a technology that has seen reduction in cost and increase in sensitivity in recent years.
Strong growth is predicted in the Swiss preventive healthcare market, from CHF 2.9 billion in 2022 up to CHF 7.7 billion in 2028.
Maven Health generates an accurate picture of personal metabolic health through our proprietary data platform which combines machine learning algorithms, data infrastructure and metabolomics. The goal is to empower primary healthcare providers to identify people at risk of metabolic diseases but who would otherwise be missed by the traditional healthcare system. Maven Health closely collaborates with primary care providers to finetune the specific targets and outcomes of their testing, making their outputs directly applicable to the current healthcare system.
The health analyses are generated from the metabolite profiles of saliva, which is collected non-invasively. Metabolites are measured by Nuclear Magnetic Resonance, a technology that has seen reduction in cost and increase in sensitivity in recent years.
Strong growth is predicted in the Swiss preventive healthcare market, from CHF 2.9 billion in 2022 up to CHF 7.7 billion in 2028.
Location: Switzerland, Vaud, Lausanne
Employees: 1-10
Investors 1
Date | Name | Website |
- | Venture Ki... | venturekic... |
Mentions in press and media 9
Date | Title | Description |
14.04.2025 | Investors support saliva metabolomics testing | Founded in 2024 by Kevin Hof and Christopher Wall, Maven Health is specialized in Saliva-based metabolomics, a scientific approach that involves the comprehensive analysis of metabolites present in saliva to gain insights into biological p... |
22.10.2024 | European funding to tackle bacterial infections and gut issues | BioVersys continues to make progress in its clinical endeavour to develop novel antibacterial products for serious life-threatening infections caused by multi-drug resistant ("MDR") bacteria. The company has joined the EU-funded ... |
29.07.2024 | Maven Health launches in Switzerland and expands to the Netherlands | Founded in 2024 in Zurich, Maven Health helps to support lifestyle changes and combat early signs of metabolic dysregulation. The company developed a Metabolic Insights test which utilizes Nuclear Magnetic Resonance (NMR) technology to ana... |
13.06.2024 | Eight Swiss startups explore business opportunities in Mexico | Academia Industry Training (AIT) is an accelerator program organized by the Leading House for the Latin American Region and AMEXCID. Covering all expenses, the program consists of a training camp in Switzerland and a second training camp i... |
24.01.2024 | Four academic venture projects get FIT Grants | Maven Health revolutionises the prevention and screening of metabolic diseases Maven Health, a spin-off from EPFL, aims to revolutionise the prevention and screening of metabolic diseases, which represent a significant burden for the Swiss... |
06.02.2023 | Ten Swiss sciencepreneurs to explore Singapore | |
01.02.2023 | AIT Singapore: Ten sciencepreneurs prepare to dive into the innovation hub of South-East Asia | AIT Singapore: Ten sciencepreneurs prepare to dive into the innovation hub of South-East Asia 01.02.2023 16:30, Morgane Ghilardi linkedIn facebook twitter instagram youtube --> On Wednesday, we welcomed ten sciencepreneurs selected to ta... |
29.12.2022 | Three aspiring startups secure capital from the Wingman campus Fund | |
11.08.2022 | Startup developing a safe laser powder bed fusion machine, a plastic action and circular economy platform, drug therapies for bone health, a personal metabolic health analysis platform, and an autonom... | a-metal: Making metal 3d printing more accessible to the broad industry Today, there are many obstacles for SMEs or inexperienced enterprises to get into additive manufacturing technologies. Especially for metal-based AM technologies, machi... |